Comparison of pain, pain burden, coping strategies, and attitudes between patients with systemic sclerosis and patients with rheumatoid arthritis: A cross-sectional study

Pain Medicine (United States)

Volumn 14, Issue 11, 2013, Pages 1776-1785

  Perrot, Serge ^a   Dieudé, Philippe ^b   Pérocheau, Dominique ^a   Allanore, Yannick ^c  

^a HÔTEL DIEU   (France)

^b BICHAT HOSPITAL   (France)

^c université Paris Cité   (France)

Author keywords

Catastrophizing; Coping Strategies; Pain; Rheumatoid Arthritis; Systemic Sclerosis

Indexed keywords

ADULT; ARTICLE; CATASTROPHIZING; COHORT ANALYSIS; COPING BEHAVIOR; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DISEASE ACTIVITY; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PAIN BURDEN; PAIN PARAMETERS; PATIENT ATTITUDE; PSYCHOLOGIC ASSESSMENT; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; UNIVERSITY HOSPITAL;

CATASTROPHIZING; COPING STRATEGIES; PAIN; RHEUMATOID ARTHRITIS; SYSTEMIC SCLEROSIS;

ADAPTATION, PSYCHOLOGICAL; ARTHRITIS, RHEUMATOID; CATASTROPHIZATION; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PAIN; QUALITY OF LIFE; SCLERODERMA, SYSTEMIC;

EID: 84887822292     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/pme.12213     Document Type: Article

References (46)

1. Barnes J, Mayes MD. Epidemiology of systemic sclerosis: Incidence, prevalence, survival, risk factors, malignancy, and environmental triggers. Curr Opin Rheumatol 2012;24:165-170.
2. Allanore Y, Dieude P, Boileau C. Updating the genetics of systemic sclerosis. Curr Opin Rheumatol 2010;22:665-670.
3. LeRoy EC, Black C, Fleischmajer R, etal. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988;15:202-205.
4. Benrud-Larson LM, Haythornthwaite JA, Heinberg LJ, etal. The impact of pain and symptoms of depression in scleroderma. Pain 2002;95:267-275.
5. Georges C, Chassany O, Toledano C, etal. Impact of pain in health-related quality of life of patients with systemic sclerosis. Rheumatology 2006;45:1298-1302.
6. Suarez-Almazor ME, Kallen MA, Roundtree AK, Mayes M. Disease and symptom burden in systemic sclerosis: A patient perspective. J Rheumatol 2007;34:1718-1726.
7. Schieir O, Thombs BD, Hudson M, etal.; Canadian Scleroderma Research Group. Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis. Arthritis Care Res 2010;62:409-417.
8. Bassel M, Hudson M, Taillefer SS, etal. Frequency and impact of symptoms experienced by patients with systemic sclerosis: Results from a Canadian National Survey. Rheumatology 2011;50:762-767.
9. El-Baalbaki G, Lober J, Hudson M, Baron M, Thombs BD; Canadian Scleroderma Research Group. Measuring pain in systemic sclerosis: Comparison of the short-form McGill Pain Questionnaire versus a single-item measure of pain. J Rheumatol 2011;38:2581-2587.
10. Arnett FC, Edworthy SM, Bloch DA, etal. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324.
11. Medsger TA Jr, Silman AJ, Steen VD, etal. A disease severity scale for systemic sclerosis: Development and testing. J Rheumatol 1999;26:2159-2167.
12. Valentini G, Della Rossa A, Bombardieri S, etal. European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 2001;60:592-598.
13. Wells G, Becker JC, Teng J, etal. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis 2009;68:954-960.
14. Bruce B, Fries JF. The health assessment questionnaire (HAQ). Clin Exp Rheumatol 2005;23:S14-18.
15. Melzack R. The short-form Mcgill Pain Questionnaire. Pain 1987;30:191-197.
16. Wright KD, Asmundson GJ, McCreary DR. Factorial validity of the short-form McGill Pain Questionnaire (SF-MPQ). Eur J Pain 2001;5:279-284.
17. Bouhassira D, Attal N, Alchaar H, etal. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005;114:29-36.
18. Cleeland CS, Ryan KM. Pain assessment: Global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994;23:129-138.
19. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.
20. Sullivan MJL, Bishop SR, Pivik J. The pain catastrophizing scale: Development and validation. Psychol Assess 1995;7:524-532.
21. Duquette J, McKinley PA, Litowski J. Test-retest reliability and internal consistency of the Quebec-French version of the Survey of Pain Attitudes. Arch Phys Med Rehabil 2005;86:782-788.
22. Tait RC, Chibnall JT. Development of a brief version of the Survey of Pain Attitudes. Pain 1997;70:229-235.
23. McHoreny CA, Ware JE, Raczek AE. The MOS-36 item Short-Form Health-Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-263.
24. Carmona L, Ballina J, Gabriel R, Laffon A. The burden of musculoskeletal diseases in the general population of Spain: Results from a national survey. Ann Rheum Dis 2001;60:1040-1045.
25. Carreira PE. "Quality of pain" in systemic sclerosis. Rheumatology (Oxford) 2006;45:1185-1186.
26. Avouac J, Walker U, Tyndall A, etal. Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: Results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol 2012;37:1488-1501.
27. Danieli E, Airo P, Bettoni L, etal. Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: Correlations with indexes of disease activity and severity, disability, and depressive symptoms. Clin Rheumatol 2005;24:48-54.
28. Malcarne VL, Hansdottir I, McKinney A, etal. Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis. J Rheumatol 2007;34:359-367.
29. Richards HL, Herrick AL, Griffin K, etal. Systemic sclerosis: Patients' perceptions of their condition. Arthritis Rheum 2003;49:689-696.
30. Johnson SR, Gladman DD, Schentag CT, Lee P. Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases. J Rheumatol 2006;33:1117-1122.
31. Treede RD, Jensen TS, Campbell JN, etal. Neuropathic pain: Redefinition and a grading system for clinical and research purposes. Neurology 2008;70:1630-1635.
32. Matsuura E, Ohta A, Kanegae F, etal. Frequency and analysis of factors closely associated with the development of depressive symptoms in patients with scleroderma. J Rheumatol 2003;30:1782-1787.
33. Legendre C, Allanore Y, Ferrand I, Kahan A. Evaluation of depression and anxiety in patients with systemic sclerosis. Joint Bone Spine 2005;72:408-411.
34. Nguyen C, Bérezné A, Baubet T, etal.; Groupe Français de Recherche sur la Sclérodermie. Association of gender with clinical expression, quality of life, disability, and depression and anxiety in patients with systemic sclerosis. PLoS ONE 2011;6:e17551.
35. Thombs BD, Fuss S, Hudson M, etal.; Canadian Scleroderma Research Group. High rates of depressive symptoms among patients with systemic sclerosis are not explained by differential reporting of somatic symptoms. Arthritis Rheum 2008;59:431-437.
36. Callahan LF, Kaplan MR, Pincus T. The Beck Depression Inventory, Center for Epidemiological Studies Depression Scale (CES-D), and General Well-Being Schedule depression subscale in rheumatoid arthritis: Criterion contamination of responses. Arthritis Care Res 1991;4:3-11.
37. Nietert PJ, Mitchell HC, Bolster MB, etal. Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis. J Rheumatol 2005;32:51-57.
38. Hyphantis TN, Tsifetaki N, Pappa C, etal. Clinical features and personality traits associated with psychological distress in systemic sclerosis patients. J Psychosom Res 2007;62:47-56.
39. Edwards RR, Goble L, Kwan A, etal. Catastrophizing, pain, and social adjustment in scleroderma: Relationships with educational level. Clin J Pain 2006;22:639-646.
40. Sinclair VG. Predictors of pain catastrophizing in women with rheumatoid arthritis. Arch Psychiatr Nurs 2001;15:279-288.
41. Jensen MP, Karoly P, Huger R. The development and preliminary validation of an instrument to assess patients' attitudes towards pain. J Psychosom Res 1987;31:393-400.
42. Shutty MS, DeGood DE. Chronic pain patients' beliefs about their pain and treatment outcomes. Arch Phys Med Rehabil 1990;71:128-132.
43. Grisart J, Masquelier E, Ophoven E. Adaptation et validation en français d'un questionnaire d'attitudes vis-à-vis de la douleur chronique étude préliminaire. Douleur Analg 1999;12:299-303.
44. Sandqvist G, Scheja A, Hesselstrand R. Pain, fatigue and hand function closely correlated to work ability and employment status in systemic sclerosis. Rheumatology (Oxford) 2010;49:1739-1746.
45. Frech T, Hays RD, Maranian P, etal. Prevalence and correlates of sleep disturbance in systemic sclerosis-Results from the UCLA scleroderma quality of life study. Rheumatology (Oxford) 2011;50:1280-1287.
46. Milette K, Razykov I, Pope J, etal. Clinical correlates of sleep problems in systemic sclerosis: The prominent role of pain. Rheumatology (Oxford) 2011;50:921-925.